Live feed16:23:47·139dINSIDERFilingvia QuantisnowChief Financial Officer Ogden Christopher was granted 90,000 shares, increasing direct ownership by 40% to 316,271 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CTMX· CytomX Therapeutics Inc.Health CareOriginal source
